LVM Capital Management’s Celgene Corp CELG Stock Holding History

LVM Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,650	Closed	-$228K	–	137
2016 Q3	$228K	Buy	+2,650	New	+$287K	0.07%	96
2015 Q1	–	Sell	-2,670	Closed	-$299K	–	122
2014 Q4	$299K	Buy	2,670 +20	+0.8%	+$2.11K	0.1%	88
2014 Q3	$251K	Hold	2,650	–	–	0.08%	93
2014 Q2	$228K	Buy	+2,650	New	+$202K	0.07%	96
2014 Q1	–	Sell	-2,570	Closed	-$217K	–	124
2013 Q4	$217K	Buy	+2,570	New	+$203K	0.08%	104

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LVM Capital Management's CELG Position: Q4 2016 in Review

LVM Capital Management sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 2,650 shares — an estimated $228K sold.

LVM Capital Management first reported a position in CELG in Q4 2013 and held it in 5 quarters. The position peaked at $299K in Q4 2014. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

LVM Capital Management reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
LVM Capital Management sold 2,650 Celgene Corp shares in Q4 2016, an estimated $228K.
LVM Capital Management first reported a position in Celgene Corp in Q4 2013 and held it in 5 quarters.
LVM Capital Management's Celgene Corp position peaked at $299K in Q4 2014.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on LVM Capital Management's 13F filing for Q4 2016, filed 9 Jan 2017.